1. Home
  2. SION vs MFH Comparison

SION vs MFH Comparison

Compare SION & MFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SION
  • MFH
  • Stock Information
  • Founded
  • SION 2019
  • MFH 2011
  • Country
  • SION United States
  • MFH United States
  • Employees
  • SION N/A
  • MFH N/A
  • Industry
  • SION
  • MFH Finance: Consumer Services
  • Sector
  • SION
  • MFH Finance
  • Exchange
  • SION NYSE
  • MFH Nasdaq
  • Market Cap
  • SION 338.0M
  • MFH 382.7M
  • IPO Year
  • SION 2025
  • MFH N/A
  • Fundamental
  • Price
  • SION $11.07
  • MFH $5.85
  • Analyst Decision
  • SION Strong Buy
  • MFH
  • Analyst Count
  • SION 1
  • MFH 0
  • Target Price
  • SION $32.00
  • MFH N/A
  • AVG Volume (30 Days)
  • SION 225.5K
  • MFH 64.6K
  • Earning Date
  • SION 05-25-2025
  • MFH 04-25-2025
  • Dividend Yield
  • SION N/A
  • MFH N/A
  • EPS Growth
  • SION N/A
  • MFH N/A
  • EPS
  • SION N/A
  • MFH N/A
  • Revenue
  • SION N/A
  • MFH $716,863.00
  • Revenue This Year
  • SION N/A
  • MFH N/A
  • Revenue Next Year
  • SION N/A
  • MFH N/A
  • P/E Ratio
  • SION N/A
  • MFH N/A
  • Revenue Growth
  • SION N/A
  • MFH 119.50
  • 52 Week Low
  • SION $7.26
  • MFH $1.03
  • 52 Week High
  • SION $25.19
  • MFH $8.86
  • Technical
  • Relative Strength Index (RSI)
  • SION N/A
  • MFH 54.51
  • Support Level
  • SION N/A
  • MFH $5.10
  • Resistance Level
  • SION N/A
  • MFH $5.78
  • Average True Range (ATR)
  • SION 0.00
  • MFH 0.64
  • MACD
  • SION 0.00
  • MFH 0.08
  • Stochastic Oscillator
  • SION 0.00
  • MFH 81.48

About SION SIONNA THERAPEUTICS INC

Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.

About MFH Mercurity Fintech Holding Inc.

Mercurity Fintech Holding Inc is a New York-based digital fintech leader providing access to the rapidly growing AI-powered infrastructure, blockchain, and digital assets sectors. Its three core business lines include: 1. Blockchain and digital asset solutions. 2. AI and HPC infrastructure, specializing in developing liquid cooling solutions for AI data centers. 3. Comprehensive financial services.

Share on Social Networks: